Effects of 6 Months of Dapagliflozin Treatment on Metabolic Profile and Endothelial Cell Dysfunction for Obese Type 2 Diabetes Mellitus Patients without Atherosclerotic Cardiovascular Disease

BACKGROUND: Sodium-glucose cotransporter 2 inhibitors reduce the risk of cardiovascular death in individuals with type 2 diabetes mellitus (T2DM) and cardiovascular disease, but the effect of these inhibitors on early cardiovascular disease remains unknown. This study evaluated the effect of dapagli...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Ju-Young, Park, Keun-Young, Kim, Jong-Dai, Hwang, Won-Min, Lim, Dong-Mee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society for the Study of Obesity 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7539345/
https://www.ncbi.nlm.nih.gov/pubmed/32990259
http://dx.doi.org/10.7570/jomes20040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7539345/
https://www.ncbi.nlm.nih.gov/pubmed/32990259
http://dx.doi.org/10.7570/jomes20040

Ejemplares similares